Figure 4.

Clinical and laboratory risk factors for granulomatous lymphocytic interstitial lung disease (GLILD). The figure shows the major findings involved in this multi‐systemic lymphoproliferative disorder in terms of clinical and imaging findings on the right and associated laboratory biomarkers on the left. The reduced T cell and naive T cell abnormalities, if sufficiently pronounced, would exclude these patients from the revised common variable immunodeficiency (CVID) classifications 5, 6, 7. [Colour figure can be viewed at wileyonlinelibrary.com.]